Non Dystrophic Myotonies
- LUPIN-PASS: An Observational Study to Describe the Long-term Safety and Effectiveness of Namuscla in the Symptomatic Management of Myotonia in Adult Patients with Non-dystrophic Myotonic Disorders
Acronym
|
LUPIN-PASS
|
| Intervention |
Namuscla ™ (Mexiletine) |
| Principal Investigator |
S. Vicart |
| Sponsor |
Lupin |
| Study status |
Ongoing |
| Recruitment status |
Completed |
| Population |
Adult |
Your private life is important for us
By clicking on "Accept all", you consent to the storage of cookies on your device to improve your navigation on the site, measure the site's performance, personalize the content or advertising displayed on the site and other sites. Your consent is valid for 6 months.
You can personalize your choices or withdraw your consent at any time by clicking on the "Manage my cookies" link. For more information, and in particular to consult the list of third parties operating on our site, see the Cookies policy accessible at the bottom of the page. You can personalize your choice or withdraw your consent at any time by clicking on the link "Manage my Cookies". For more information, and in particular to consult the list of third parties operating on our site, see the Cookies policy accessible at the bottom of the page.
Read moreManage my cookiesDeny all cookiesAccept allManage my cookies
